Future Immune Checkpoint Strategies

August 18, 2014
James P. Allison, PhD

Special Reports, Immunotherapy (Issue 3), Volume 3, Issue 1

James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the future of immune checkpoint strategies.

James P. Allison, PhD, director, immunotherapy platform, The University of Texas MD Anderson Cancer Center, discusses the future of immune checkpoint strategies.

Learn about the history of immunotherapy > >